Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Public ClinicalTrials.gov record NCT05857969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Adopting a Functional Precision Medicine Approach For Individualized Pediatric Cancer Treatments
Study identification
- NCT ID
- NCT05857969
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Florida International University
- Other
- Enrollment
- 65 participants
Conditions and interventions
Conditions
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
- Recurrent Childhood Brain Tumor
- Recurrent Childhood Brainstem Glioma
- Recurrent Childhood Ependymoma
- Recurrent Childhood Gliosarcoma
- Recurrent Childhood Large Cell Lymphoma
- Recurrent Childhood Lymphoblastic Lymphoma
- Recurrent Childhood Malignant Neoplasm
- Recurrent Childhood Malignant Solid Neoplasm
- Recurrent Childhood Rhabdomyosarcoma
- Recurrent Childhood Soft Tissue Sarcoma
- Refractory Childhood Acute Lymphoblastic Leukemia
- Refractory Childhood Hodgkin Lymphoma
- Refractory Childhood Malignant Germ Cell Neoplasm
- Refractory Childhood Malignant Neoplasm
- Refractory Childhood Malignant Solid Neoplasm
- Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Interventions
- Functional Precision Medicine Device
Device
Eligibility (public fields only)
- Age range
- 1 Day to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2023
- Primary completion
- Feb 21, 2028
- Completion
- Dec 30, 2028
- Last update posted
- Jul 10, 2025
2023 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nicklaus Children's Hospital | Miami | Florida | 33155 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05857969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05857969 live on ClinicalTrials.gov.